Live Breaking News & Updates on David Lamond

Stay updated with breaking news from David lamond. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Quince Therapeutics, Inc. (NASDAQ:QNCX) Director Buys $22,773.54 in Stock

Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) Director David Lamond bought 22,327 shares of the company’s stock in a transaction on Tuesday, December 12th. The stock was bought at an average price of $1.02 per share, for a total transaction of $22,773.54. Following the completion of the purchase, the director now directly owns 2,302,291 […] ....

David Lamond , Quince Therapeutics Company Profile , Cortexyme Inc , Renaissance Technologies , Capital Management , Millennium Management , Securities Exchange Commission , Blackrock Inc , Quince Therapeutics Inc , Quince Therapeutics , Get Free Report , Director David Lamond , Exchange Commission , Sigma Investments , Quince Therapeutics Daily , Nasdaq Qncx , Insider Trading , Nsider Trades ,